Mitralign Inc.

Mitralign Inc.'s percutaneous approach to mitral valve repair mimics surgical annuloplasty, the current gold standard treatment for reducing the dilated annulus to a functional size. The company is targeting patients who have both congestive heart failure and mitral valve regurgitation.